Puma Biotechnology Inc (NASDAQ:PBYI)
| 9.73 Delayed Data As of Jan 17 |  +0.84 / +9.39%Today’s Change | 6.26 Today|||52-Week Range 43.90 | +11.20% Year-to-Date |
Latest PBYI News | Press Releases
| Is Puma Biotechnology a Buy? Jan 08 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 8.90 |
| Today’s open | 8.95 |
| Day’s range | 8.90 - 9.86 |
| Volume | 3,330,283 |
| Average volume (3 months) | 1,742,814 |
| Market cap | $383.0M |
Data as of 4:00pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +61.87% |
| Earnings growth (this year) | +30.22% |
| Earnings growth (next 5 years) | +260.25% |
| Revenue growth (last year) | +806.60% |
| P/E ratio | NM |
| Price/Sales | 3.08 |
| Price/Book | 10.98 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRQRProQR Therapeutics N... | -0.35 | -4.17% |
| EOLSEvolus Inc | +0.12 | +1.07% |
| SPPISpectrum Pharmaceuti... | -0.05 | -1.52% |
| REPHRecro Pharma Inc | -0.16 | -1.01% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.49 |
| Annual revenue (last year) | $251.0M |
| Annual profit (last year) | -$113.6M |
| Net profit margin | -45.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
